NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Scientific & Technical Instruments · USD

Ainos, Inc. (AIMD) Stock Analysis

Ainos, Inc. (AIMD) is a Scientific & Technical Instruments stock listed on NASDAQ and quoted in US Dollar.

AIMD

$1.60

+$0.04 (+2.56%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AIMD with… →

AIMD Key Statistics

As of Sep 4, 2026
Trading
Open
$1.57
Previous Close
$1.56
Day's Range
1.51–1.65
52-Week Range
1.26–4.44
Volume
46.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.48
Valuation
Market Cap
$11.81M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.93
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
868.71
EPS (ttm)Profit attributable to each share over the last twelve months.
−2.50
Financials (FY)
Revenue (FY)
$124.16K+498.95%
Net Income (FY)
−$14.77M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
7.38M
1-Year Return
−55.92%
Dividend and dates
Avg Volume
99.82K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

AIMD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−2.44%
2025−28.07%
2024−77.76%
2023−33.87%
2022−95.08%
2021+449.02%

As of September 4, 2026.

AIMD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$124.16K−$14.77M−11897.0%
2024$20.73K−$14.86M−71702.3%
2023$122.11K−$13.77M−11277.0%
2022$3.52M−$14.01M−398.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$124.16K$102.91K−$13.99M−$14.77M−11897.0%
2024$20.73K−$31.87K−$13.84M−$14.86M−71702.3%
2023$122.11K−$253.73K−$13.21M−$13.77M−11277.0%
2022$3.52M$1.41M−$13.98M−$14.01M−398.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

AIMD Valuation vs Scientific & Technical Instruments Median

Median of 35 stocks
MetricAIMDScientific & Technical Instruments medianvs median
P/S ratio868.715.24165.6x the median
Profit margin0.00%2.42%2.4 pts below

Medians across 35 Scientific & Technical Instruments stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Ainos, Inc. (AIMD) carries a market capitalisation of $11.81M. It is classified in the Scientific & Technical Instruments industry, within the Technology sector. Headcount on file is 41.

The most recent close on file for AIMD is $1.60, dated September 4, 2026. That is +$0.04 (+2.56%) against the previous close. The 52-week range on file runs from $1.26 to $4.44. The latest close sits 26.98% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $124.16K. Against the prior fiscal year total of $20.73K, that is a change of +498.95%. The same year closed with a net loss of $14.77M. The reported profit margin is 0%. That is 2.4 percentage points below the Scientific & Technical Instruments median of 2.42%. Earnings per share on a trailing basis come to −2.5.

Across the 4 fiscal years on file, revenue moves from $3.52M in 2022 to $124.16K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.93. The price-to-sales ratio is 868.71. On price-to-sales that is 165.6 times the Scientific & Technical Instruments median of 5.24. 35 Scientific & Technical Instruments companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −55.92%. Measured over 5 years, that is −64.91% a year compounded. Beta against the wider market is reported at 2.49. Annualized volatility over the trailing 5 years is 236.05%.

Growth & Income

The record shows no dividend for AIMD.

The strongest complete calendar year on file is 2021 at +449.02%; the weakest is 2022 at −95.08%. Of the 5 complete calendar years on file, 1 finished higher. So far in 2026 the price is −2.44%.

Peer Comparison

Ainos, Inc. (AIMD) operates in the Scientific & Technical Instruments industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Ainos, Inc. AIMD $11.81M —
Keysight Technologies, Inc. KEYS $55.71B 43.7
Coherent Corp. COHR $55.20B 64.1
Garmin Ltd. GRMN $53.43B 28.6

The Scientific & Technical Instruments industry average P/E ratio is 39.1x. Ainos, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Scientific & Technical Instruments Stocks

KEYS

Keysight Technologies, Inc.

$55.71B

 COHR

Coherent Corp.

$55.20B

 GRMN

Garmin Ltd.

$53.43B

 TDY

Teledyne Technologies Incorporated

$28.31B

 MKSI

MKS Inc.

$17.60B

 FTV

Fortive Corporation

$17.20B
View all Scientific & Technical Instruments stocks →

Popular Technology Stocks

NVDA

NVIDIA Corporation

$5.56T

 AAPL

Apple Inc.

$4.67T

 MSFT

Microsoft Corporation

$3.71T

 TSM

Taiwan Semiconductor Manufacturing Company Limited

$2.22T

 AVGO

Broadcom Inc.

$1.70T
View all Technology stocks →

About Ainos, Inc.

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Visit website →